P11-03. Mucosal trafficking and differentiation of vaccine-elicited CD8+ T-lymphocytes by Barouch DH, Simmons NL, Kaufman DR

Adenovirus vectors from various serotypes induce distinct cytokine profiles by Teigler JE, Iampietro M, Barouch DH

Novel Adenovirus Vector-Based Vaccines for HIV by Letvin N, Barouch DH, Havenga M, Goudsmit J

P10-06. Adaptive immune responses elicited by recombinant adenovirus vectors exhibit partial MyD88 dependence by Barouch DH, Kasturi SP, Pulendran B, Rhee EG

Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following SIV challenges of vaccinated monkeys by Stephenson KE, Li H, Walker BD, Michael NL, Barouch DH

Humoral immune response profiling with peptide microarrays by Reimer U, Wenschuh H, Baden LR, Pau M, Weijtens M, Barouch DH

Adenovirus serotype 26 utilizes CD46 as primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys by Li H, Rhee EG, Masek-Hammerman K, Teigler JE, Abbink P, Barouch DH

Full-length HIV-1 immunogens induce greater T lymphocyte responses to conserved epitopes than conserved-region-only HIV-1 immunogens in monkeys by Stephenson KE, SanMiguel A, Simmons NL, Smith K, Szinger JJ, Korber BT, Barouch DH

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses by Penaloza P, Borducchi E, McNally A, Simmons N, Teigler J, Provine N, Tan W, Ahmed R, Barouch DH

P17-22. Impact of rare adenovirus seroprevalence on HIV-1 acquisition in the Step study by Barouch DH, Goudsmit J, McElrath MJ, Hural J, LaPorte A, Dilan R, Riggs AM, King SL, Maxfield LF

First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine by Walsh SR, Seaman MS, Johnson JA, Tucker RP, Krause KH, Weijtens M, Pau MG, Goudsmit J, Dolin R, Barouch DH, Baden LR

Evidence for Env-V2 sieve effect in breakthrough SIV _MAC251 infections in rhesus monkeys vaccinated with Ad26/MVA and MVA/Ad26 constructs by Sina S, Tovanabutra S, Sanders-Buell E, Bates A, Bose M, Howell S, Ibitamuno G, Lazzaro M, O'Sullivan A, Lee J, Cervenka T, Kuroiwa J, Baldwin K, Barouch DH, Robb M, O'Connell R, Michael NL, Kim JH, Rolland M

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines by López-Camacho, C, De Lorenzo, G, Slon-Campos, JL, Dowall, S, Abbink, P, Larocca, RA, Kim, YC, Poggianella, M, Graham, V, Findlay-Wilson, S, Rayner, E, Carmichael, J, Dejnirattisai, W, Boyd, M, Hewson, R, Mongkolsapaya, J, Screaton, GR, Barouch, DH, Burrone, OR, Patelm AH, Reyes-Sandoval, A